ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,125.21
1.20%
Dow Jones
38,668.56
1.16%
US Dollar vs MXN
17.0104
0.22%
Brent Oil
83.175
-0.54%
Bitcoin
61,592.67
4.18%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Sucampo Pharmaceuticals, Inc. (delisted) (SCMP)

  7. Sucampo Pharmaceuticals, Inc. (delisted) (SCMP) Noticias

SCMP

Sucampo Pharmaceuticals, Inc. (delisted) (SCMP)

Sucampo Pharmaceuticals, Inc. (delisted)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SCMP
FechaHoraFuenteTítuloSímboloCompañía
23/02/201807:27Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
16/02/201805:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
15/02/201815:49Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
14/02/201817:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
13/02/201815:10Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
13/02/201814:51Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
13/02/201810:17Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
13/02/201809:59Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
13/02/201809:19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
13/02/201808:26Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
13/02/201808:16Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
13/02/201808:08Edgar (US Regulatory)(25-NSE)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
06/02/201816:53PR Newswire (US)Boyd Gaming Set to Join S&P MidCap 400; Ring Energy, James River Group Holdings and EVERTEC to Join S&P SmallCap 600NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
16/01/201815:55Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
16/01/201815:34Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
27/12/201716:31Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
26/12/201706:43Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
26/12/201705:45PR Newswire (US)Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 BillionNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
28/11/201705:35PR Newswire (US)Free Research Reports on These Healthcare Stocks -- Sanofi, DURECT, Sucampo Pharma, and PerrigoNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
27/11/201715:10GlobeNewswire Inc.Sucampo Pharmaceuticals Announces its Participation at the Global Mizuho Investor ConferenceNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
21/11/201715:10GlobeNewswire Inc.Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 29th Annual Piper Jaffray Healthcare ConferenceNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
09/11/201716:48GlobeNewswire Inc.Sucampo to Host 2017 R&D Day on November 16 in New YorkNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
02/11/201715:13Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
01/11/201705:37Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
01/11/201705:30GlobeNewswire Inc.Sucampo Reports Third Quarter 2017 Financial ResultsNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
23/10/201715:05GlobeNewswire Inc.Sucampo Announces Third Quarter 2017 Earnings CallNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
28/09/201716:35GlobeNewswire Inc.Sucampo Pharmaceuticals Announces FDA Acceptance of sNDA for AMITIZA in Children with Pediatric Functional Constipation, with...NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
27/09/201719:43GlobeNewswire Inc.Sucampo Pharmaceuticals Announces Presentation at Deutsche Bank’s 25th Annual Leveraged Finance ConferenceNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
21/09/201707:25GlobeNewswire Inc.Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Partners Roundtable Series: Rare Disease & ...NASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
20/09/201715:15GlobeNewswire Inc.Sucampo Pharmaceuticals Appoints Alex Driggs as General CounselNASDAQ:SCMPSucampo Pharmaceuticals, Inc. (delisted)
 Showing the most relevant articles for your search:NASDAQ:SCMP

Su Consulta Reciente

USI
USTECH100
US Tech 100
COIN
BTCUSD
Bitcoin
NYSE
KO
Coca Cola
CCOM
US500
US 500
NASDAQ
TSLA
Tesla
AMEX
XLE
Energy Select Sector SPDR
NYSE
XOM
Exxon Mobil
NYSE
NKE
Nike
NYSE
VZ
Verizon Communications
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
ADDYY
Adidas (QX)
SPI
SP500
S&P 500
NYSE
AXP
American Express
NYSE
MCD
McDonalds
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados